All the latest news relating to paedatric oncology and adolescents and young adults with cancer
FDA approves brentuximab vedotin in combination with chemotherapy for paediatric patients with classical Hodgkin lymphoma
The Food and Drug Administration approved brentuximab vedotin in combination with doxorubicin, vincristine, etoposide, prednisone, and…